Science, Technology, Insurance
As an authoritative resource in stochastic risk modeling, mathematical biology, and epidemiology, LifeRisks combines modeling science, technology, and insurance expertise.
Forward-Looking Mortality Model
Detailed analysis of "vitagions" – drivers of mortality improvement – provides a framework to project medium- and long-term dynamics of mortality trends.
Understand Extreme Mortality
Combine the latest infectious disease modeling alongside individual perils that cause mortality shocks such as terrorism and earthquake, to deliver insightful causal analysis.
Drill down into model results to understand risk drivers and identify scenarios that represent key loss thresholds.
Independent and Impartial
RMS provides impartial risk analysis, as our models support insurers, reinsurers, intermediaries, and the capital markets.
RMS COVID-19 Pandemic Projections
Access 3 to 6 month projections to support longer term decision-making.
Keep informed about the COVID-19 pandemic and its implications for the risk management industry. Visit the dedicated COVID-19 resources hub page, with a range of resources from webinars and reports to explore.
Infectious Disease Model (IDM)
RMS pioneered the probabilistic quantification of infectious disease risk with the release of IDM in 2006. The stochastic event set covers influenza and emerging infectious disease pandemics, including coronaviruses. The IDM incorporates the latest scientific research related to human mortality. Model output supports pandemic planning, portfolio management, risk transfer and capital adequacy stress-testing.
Swiss Re Chooses RMS for Pandemic Risk
RMS was selected by Swiss Re for the 2020 reissuance of its excess mortality bond (‘Matterhorn’). RMS models provided in-depth insights into the risk of extreme mortality from a variety of perils, most notably pandemics and terror attacks. The bond was well-received by investors, taking Swiss Re’s protection from the Matterhorn program to US$855 million.